Jiangxi Wannianqing Cement (301111.SZ) stated on the investor interaction platform on July 11 that the company has no current involvement in the planting industry of traditional Chinese medicine. The company focuses on the research and development, production and sales of Chinese patent medicine, and has a close relationship with upstream traditional Chinese medicine materials. The fluctuation of traditional Chinese medicine material prices has a certain degree of impact on the company's production costs, while the company's product prices are considered comprehensively based on objective environment, market demand, and product costs, so the impact of traditional Chinese medicine material price increases on the company's performance cannot be generalized.